Incyte Corp (NASDAQ: INCY) has reported a loss for its second fiscal quarter (ending June 30) of $-2.04 versus $0.91 for the same period a year ago. E.P.S. were $0.42 for the latest four quarters through June 30 versus $1.65 for the same period a year ago.
Recent Price Action
Incyte Corp (NASDAQ: INCY) stock declined modestly by -1.2% on 7/30/24. The stock closed at $67.79. This decline was accompanied by normal trading volume. The stock has performed in line with the market over the last nine months and has risen 4.0% during the last week.
Current PriceTarget Research Rating
INCY’s future returns on capital are forecasted to exceed the cost of capital. Accordingly, the company is expected to continue to be an important Value Builder.
Incyte has a current Value Trend Rating of C (High Neutral). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Incyte has a slightly positive Appreciation Score of 69 and a neutral Power Rating of 45, leading to the High Neutral Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment